|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.195 RON | -3.47% |
|
-5.34% | -2.50% |
| 04-25 | S.C. Ropharma S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | S.C. Ropharma S.A. Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
S.C. Ropharma S.A. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was RON 1,006.36 million compared to RON 912.74 million a year ago. Revenue was RON 1,122.41 million compared to RON 1,004.85 million a year ago.
Net income was RON 7.72 million compared to RON 9.22 million a year ago. Basic earnings per share from continuing operations was RON 0.015 compared to RON 0.018 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -2.50% | 21.39M | |
| -19.86% | 3.25B | |
| -28.53% | 2.84B | |
| +4.99% | 2.47B | |
| -16.49% | 2.14B | |
| -6.58% | 1.78B | |
| +19.41% | 1.46B | |
| -31.47% | 868M | |
| -51.69% | 560M | |
| -0.53% | 425M |
S.C. ROPHARMA S.A. 
